|
|
|
|
Cardiff Lexington Corporation (CDIF) |
|
|
|
| |
CDIF's Revenue Growth by Quarter and Year
Cardiff Lexington's Revenue results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| CDIF Revenue (in millions $) |
FY 2024 |
FY 2023 |
FY 2022 |
FY 2021 |
| IV Quarter |
December |
3.12
|
2.07
|
2.57
|
3.58
|
| III Quarter |
September |
1.36
|
3.44
|
3.36
|
3.31
|
| II Quarter |
June |
1.47
|
3.48
|
3.13
|
2.18
|
| I Quarter |
March |
2.32
|
2.86
|
2.94
|
0.93
|
| FY |
|
8.27
|
11.85
|
12.00
|
10.00
|
| CDIF Revenue fourth quarter 2024 Y/Y Growth Comment |
Cardiff Lexington Corporation achieved in the fourth quarter 2024, above Company average Revenue rise of 50.76% year on year, to $ 3.12 millions.
Looking into fourth quarter 2024 results within Healthcare Facilities industry 28 other companies have achieved higher Revenue growth. While Cardiff Lexington Corporation' s Revenue jump of 50.76% ranks overall at the positon no. 2126 in the fourth quarter 2024.
|
| CDIF Revenue ( Y/Y Growth %) |
2024
|
2023 |
2022 |
2021 |
| IV Quarter |
December |
50.76 % |
-19.46 % |
-28.21 % |
468.25 % |
| III Quarter |
September |
-60.47 % |
2.38 % |
1.51 % |
366.2 % |
| II Quarter |
June |
-57.76 % |
11.18 % |
43.58 % |
120.2 % |
| I Quarter |
March |
-18.88 % |
-2.72 % |
216.13 % |
-16.96 % |
| FY |
|
-30.2 % |
-1.25 % |
20 % |
189.86 % |
CDIF Revenue (Quarter on Quarter Growth %) |
2024
|
2023 |
2022 |
2021 |
| IV Quarter |
December |
129.46 % |
-39.83 % |
-23.51 % |
8.16 % |
| III Quarter |
September |
-7.48 % |
-1.15 % |
7.35 % |
51.83 % |
| II Quarter |
June |
-36.64 % |
21.68 % |
6.46 % |
134.41 % |
| I Quarter |
March |
12.08 % |
11.28 % |
-17.88 % |
47.62 % |
| FY (Year on Year) |
|
-30.2 % |
-1.25 % |
20 % |
189.86 % |
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 267.79 % |
49.33 % |
-41.52 % |
| (Mar 31 2022) |
|
(Sep 30 2024) |
|
|
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 267.79 % |
49.33 % |
-41.52 % |
| (Mar 31 2022) |
|
(Sep 30 2024) |
|
| Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024 |
Cardiff Lexington's Q/Q Revenue Growth
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 134.23 % |
13.57 % |
-43.22 % |
| (Jun 30 2021) |
|
|
| CDIF's IV. Quarter Q/Q Revenue Comment |
Cardiff Lexington Corporation achieved in the IV. Quarter 2024 above company average sequential Revenue doubling of 129.46%, to $ 3.12 millions, from $1.36 millions in the third quarter.
CDIF is going from strength to strength, not just recording better then regular growth, but also increasing rate.
Within Healthcare Facilities industry Cardiff Lexington Corporation achieved highest sequential Revenue growth. While Cardiff Lexington's Revenue growth quarter on quarter, overall rank is 99. |
|
|
|
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 134.23 % |
13.57 % |
-43.22 % |
| (Jun 30 2021) |
|
|
| CDIF's IV. Quarter Q/Q Revenue Comment |
Cardiff Lexington Corporation achieved in the IV. Quarter 2024 above company average sequential Revenue doubling of 129.46%, to $ 3.12 millions, from $1.36 millions in the third quarter.
CDIF is undergoing a remarkable growth, with reporting above regular increase, and also improving pace,Most analysts added.
Within Healthcare Facilities industry Cardiff Lexington Corporation achieved highest sequential Revenue growth. While Cardiff Lexington's Revenue growth quarter on quarter, overall rank is 99. |
|
Cardiff Lexington's 12 Months Revenue Growth Year on Year
Revenue TTM Growth |
12 Months Ending
(Dec 31 2024) |
12 Months Ending
(Sep 30 2024) |
12 Months Ending
(Jun 30 2024) |
12 Months Ending
(Mar 31 2024) |
12 Months Ending
(Dec 31 2023) |
| Cumulative Revenue 12 Months Ending |
$ 8.27 |
$ 7.22 |
$ 9.30 |
$ 11.31 |
$ 11.85 |
| Y / Y Revenue Growth (TTM) |
-30.23 % |
-41.52 % |
-24.18 % |
-5.06 % |
-1.21 % |
| Year on Year Revenue Growth Overall
Ranking |
# 1901 |
# 2413 |
# 2343 |
# 1435 |
# 562 |
| Seqeuential Revenue Change (TTM) |
14.53 % |
-22.38 % |
-17.77 % |
-4.54 % |
-4 % |
| Seq. Revenue Growth (TTM) Overall
Ranking |
# 2126 |
# 1902 |
# 1733 |
# 1616 |
# 2140 |
| Cumulative Revenue growth
Comment |
Cardiff Lexington showed decline, but improvement compare to trailing twelve month Revenue decrease in Sep 30 2024. If the fiscal year would end in Dec 31 2024, Cardiff Lexington's annual Revenue decline would be -30.23% year on year to $8 millions.
In the Healthcare sector 275 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1901, from total ranking in previous quarter at 2413. |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
267.79 % |
49.33 % |
-41.52 % |
|
|
|
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
267.79 % |
49.33 % |
-41.52 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 29 |
| Sector |
# 298 |
| S&P 500 |
# 2126 |
|
| Cumulative Revenue growth
Comment |
Cardiff Lexington showed decline, but improvement compare to trailing twelve month Revenue decrease in Sep 30 2024. If the fiscal year would end in Dec 31 2024, Cardiff Lexington's annual Revenue drop would be -30.23% year on year to $8 millions.
In the Healthcare sector 275 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1901, from total ranking in previous quarter at 2413. |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
267.79 % |
49.33 % |
-41.52 % |
|
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
267.79 % |
49.33 % |
-41.52 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 29 |
| Sector |
# 298 |
| S&P 500 |
# 2126 |
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
88.19%